Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal human malignant tumor, with a dismal 5-year survival rate of less than 5%. The lack of specific symptoms at early tumor stages and the paucity of biomarkers contribute to the poor diagnosis of pancreatic ductal adenocarcinoma. To improve pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongzhe, Wang, Xinjing, Fang, Yuan, Huo, Zhen, Lu, Xiongxiong, Zhan, Xi, Deng, Xiaxin, Peng, Chenghong, Shen, Baiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581051/
https://www.ncbi.nlm.nih.gov/pubmed/28881752
http://dx.doi.org/10.18632/oncotarget.16732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581051/
https://www.ncbi.nlm.nih.gov/pubmed/28881752
http://dx.doi.org/10.18632/oncotarget.16732

Ejemplares similares